Opko Health Company Leadership

OPK Stock  USD 1.24  0.01  0.81%   
Opko Health's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Opko Health suggests that most insiders are extremely bullish. Opko Health employs about 3 K people. The company is managed by 19 executives with a total tenure of roughly 40 years, averaging almost 2.0 years of service per executive, having 157.74 employees per reported executive.
Phillip Frost  Chairman
Chairman of the Board, CEO
Akhtar Ashfaq  President
Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2025-11-21Phillip Md Et Al FrostAcquired 580000 @ 1.33View
2025-11-19Phillip Md Et Al FrostAcquired 580000 @ 1.31View
2025-11-18Phillip Md Et Al FrostAcquired 533300 @ 1.27View
2025-10-31Phillip Md Et Al FrostAcquired 150000 @ 1.42View
2025-08-08Phillip Md Et Al FrostAcquired 675000 @ 1.32View
2025-04-10Phillip Md Et Al FrostAcquired 125000 @ 1.36View
2025-04-08Phillip Md Et Al FrostAcquired 125000 @ 1.48View
2025-04-01Phillip Md Et Al FrostAcquired 100000 @ 1.65View
2025-03-28Phillip Md Et Al FrostAcquired 150000 @ 1.7View
2025-03-17Phillip Md Et Al FrostAcquired 200000 @ 1.74View
2025-02-28Phillip Md Et Al FrostAcquired 67434 @ 1.71View
Monitoring Opko Health's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Opko Health Management Team Effectiveness

The company has Return on Asset of (0.0615) % which means that on every $100 spent on assets, it lost $0.0615. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1332) %, meaning that it generated no profit with money invested by stockholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.06. The value of Return On Capital Employed is expected to slide to -0.07. At this time, Opko Health's Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 2.7 B this year, although the value of Non Current Liabilities Other will most likely fall to about 9.8 M.
Common Stock Shares Outstanding is expected to rise to about 838 M this year, although the value of Net Loss is projected to rise to (280.8 M). Opko Health owns a total of 767.7 Million outstanding shares. Opko Health has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
1996-03-31
Previous Quarter
671.6 M
Current Value
779.9 M
Avarage Shares Outstanding
305.1 M
Quarterly Volatility
272.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Dividends Paid is expected to rise to 3,622 this year, although the value of Dividend Yield will most likely fall to 0. Common Stock Shares Outstanding is expected to rise to about 838 M this year, although the value of Net Loss is projected to rise to (280.8 M).

Opko Health Workforce Comparison

Opko Health is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 10,299. Opko Health totals roughly 2,997 in number of employees claiming about 29% of equities under Health Care industry.

Opko Health Profit Margins

The company has Net Profit Margin of (0.28) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.35) %, which entails that for every $100 of revenue, it lost $0.35.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.540.5
Significantly Up
Slightly volatile

Opko Health Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Opko Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Opko Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Opko Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Opko Health Notable Stakeholders

An Opko Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Opko Health often face trade-offs trying to please all of them. Opko Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Opko Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Elias MDPresident ChairmanProfile
Phillip FrostChairman of the Board, CEOProfile
Phillip MDChairman CEOProfile
Arie GutmanPresident APIProfile
David OkronglyPresident DiagnosticsProfile
Antonio CruzPresident TherapeuticsProfile
Hans BernerPresident IberoamericaProfile
Akhtar AshfaqSenior Vice President - Clinical Research and Development of OPKO Health's Renal DivisionProfile
Adam LogalCFO, Chief Accounting Officer, Sr. VP and TreasurerProfile
Dr MBAVice OfficerProfile
FACP FASNSenior RenalProfile
JD EsqChief LaboratoriesProfile
Charles BishopChief RenalProfile
John MDChief ModeXProfile
James DeMarcoVP SalesProfile
Giovanni MDChief OfficerProfile
MBA MBAVice OfficerProfile
Jon MDAdvisorProfile
Damien BurkeChief PharmaProfile
String symbol = request.getParameter("s");

About Opko Health Management Performance

The success or failure of an entity such as Opko Health often depends on how effective the management is. Opko Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Opko management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Opko management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.06)(0.06)
Return On Capital Employed(0.07)(0.07)
Return On Assets(0.02)(0.02)
Return On Equity(0.04)(0.04)

Opko Health Workforce Analysis

Traditionally, organizations such as Opko Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Opko Health within its industry.

Opko Health Manpower Efficiency

Return on Opko Health Manpower

Revenue Per Employee238K
Revenue Per Executive37.5M
Net Loss Per Employee17.8K
Net Loss Per Executive2.8M
Working Capital Per Employee156.5K
Working Capital Per Executive24.7M
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. Anticipated expansion of Opko directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Opko Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.13)
Earnings Share
(0.24)
Revenue Per Share
0.881
Return On Assets
(0.06)
Return On Equity
(0.13)
The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Opko Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Opko Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Opko Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.